TGen News & Press Releases

UArizona-TGen led team identifies new biomarkers to diagnose and monitor brain injuries

Posted Friday July 31, 2020

Integrated protein and metabolite analysis open the door to more precise ways of guiding treatment for the nearly 70 million people worldwide who annually suffer traumatic brain injuries

TGen Center for Rare Childhood Disorders patient is headed to Mars

Posted Thursday July 23, 2020

Alex Yiu, whose rare neurological disorder was diagnosed by TGen, will celebrate a combination birthday and ‘Perseverance’ pre-launch party and fundraiser on July 25

Ashion Analytics announces innovative cancer treatment partnership with Elevation Oncology

Posted Wednesday July 22, 2020

Ashion Analytics GEMExTra test detects rare NRG1 gene fusions in patients whose cancer is driven by this genomic alteration for potential matching to a clinical trial

TGen, City of Hope looking to create personalized roadmaps for the treatment of kidney cancer

Posted Wednesday July 22, 2020

Physician-scientists are using one of the world’s most comprehensive genomic analysis tools to determine whether targeted therapy or immunotherapy has the best chance of working for each individual patient

Ashion Analytics receives Medicare coverage for GEM ExTra® assay for patients with advanced solid tumors

Posted Tuesday July 14, 2020

TGen identifies immune effects of a drug in aggressive ovarian cancer that strikes young women

Posted Friday July 10, 2020

SP-2577 could enable the immune system to attack ovarian cancer; clinical trials for patients expected soon

TGen-led study identifies unique cells that may drive lung fibrosis

Posted Wednesday July 8, 2020

Study with Vanderbilt University shows how the body’s attempts to repair damage may instead contribute to severe lung disease

TGen teams with Poba Medical to produce 10,000 COVID-19 test kits per month

Posted Thursday July 2, 2020

Poba Medical’s cleanroom assembly line helps TGen provide coronavirus tests for some of Arizona’s most vulnerable and underserved populations

Study led by TGen and City of Hope shows new way of identifying tumor response to immunotherapy

Posted Monday June 22, 2020

Findings could improve personalized medicine for cancer patients

TGen’s Ashion Analytics® and HonorHealth show how ‘organoids’ can help pinpoint the right therapies for cancer patients

Posted Monday June 22, 2020

New PATRIOT analysis unveiled at this week’s AACR meeting; builds on Ashion’s GEM-ExTra program, providing unprecedented accuracy in prescribing anti-cancer treatments

Prev
1
2
[3]
4
5
Next

Media Contact

Steve Yozwiak
[email protected]
602-343-8704

News Archive

View Media Release Archive

Media Contact

Newsletter

News Archive

Latest Posts

Useful Links

Contact Us

Stay up-to-date with TGen